Mentor Worldwide LLC, a global leader in breast aesthetics, today announced the availability of its MemoryGel® Xtra Breast Implants in the United States.
MENTOR® MemoryGel® Xtra — which is being showcased at the 2017 Plastic Surgery Meeting hosted by the American Society of Plastic Surgeons (ASPS) in Orlando, FL (Johnson & Johnson Medical Devices Booth #523) — is the only breast implant on the market which allows for increased projection, fullness and firmness1-3 without losing the soft, natural feel patients desire.4
“I’m excited to provide my patients with the latest breast implant option from MENTOR®,” said Dr. Louis Strock*, American Board of Plastic Surgery, Diplomate. “MemoryGel® Xtra Breast Implants offer a rare combination of a more tight feel while maintaining an overall natural softness.”
In a recent blinded brand comparison, nine out of 10 consumers chose MemoryGel® Xtra implants as feeling more like natural (or real) breasts.4,5 Surgeons also chose MemoryGel® Xtra implants as a product they would use more often at their practice.6
“For more than 30 years, approximately 5 million women have chosen MENTOR® breast implants as a safe and reliable option to achieve their desired outcome,” said Dr. John Canady, Franchise Medical Leader, Johnson & Johnson Medical Devices. “We’re always looking for ways to advance our products and meet the ever-evolving needs of our patients. The meaningful innovation of MemoryGel® Xtra not only increases options for patients but also reinforces the MENTOR® global leadership position in breast aesthetics.”
MENTOR® MemoryGel® Xtra breast implants were approved by the U.S. Food & Drug Administration in April 2017.
MENTOR® also recently launched the ARTOURA™ Breast Tissue Expander line with a smooth shell in July 2017 throughout the U.S. This new option provides an alternative for surgeons who may prefer a smooth tissue expander.